Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Tourmaline Bio, Inc., A Novartis Company

Clinical trials sponsored by Tourmaline Bio, Inc., A Novartis Company, explained in plain language.

New drug aims to calm inflammation in kidney disease patients

Disease control Completed

This study tested a drug called TOUR006 in 143 adults with chronic kidney disease and high levels of a protein linked to inflammation (hs-CRP). The goal was to see if monthly or quarterly shots could safely lower inflammation. The study is complete, and results will show if the d…

Phase: PHASE2 • Sponsor: Tourmaline Bio, Inc., a Novartis Company • Aim: Disease control

Last updated Jun 15, 2026 18:54 UTC